Stock Code: 002019 Stock Abbreviation: Yifan Pharmaceutical Announcement Number: 2026-015
Yifan Pharmaceutical Co., Ltd. Resolution Announcement of the Fourth Meeting of the Ninth Board of Directors
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
I. Convening of the Board Meeting
The Fourth Meeting of the Ninth Board of Directors of Yifan Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was notified by email on April 10, 2026, and held on April 22, 2026, in the first-floor conference room of the Company through on-site and communication voting. Ms. Liu Meijuan participated in the meeting via communication voting. Six directors were eligible to attend, and six directors actually attended. The meeting was presided over by Chairman Mr. Cheng Xianfeng, and senior management personnel of the Company were present. The convening and holding of this meeting comply with the "Company Law" and the "Company Articles of Association" and other relevant regulations.
II. Deliberation of the Board Meeting
After careful deliberation by all directors, the meeting formed the following resolutions through voting:
(I) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Company's 2025 President's Work Report."
(II) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Company's 2025 Board of Directors' Work Report." The "2025 Board of Directors' Work Report" can be found in the "Management Discussion and Analysis" in Section III and "Corporate Governance, Environment, and Society" in Section IV of the "2025 Annual Report" disclosed by the Company on the same day on the CNINFO website (http://www.cninfo.com.cn).
(III) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Company's 2025 Annual Report and its Summary." The specific content can be found in the "Company's 2025 Annual Report Summary" and the "Company's 2025 Annual Report" disclosed by the Company on the same day on the CNINFO website (http://www.cninfo.com.cn).
(IV) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Proposal on the Company's 2025 Profit Distribution Plan." The specific content can be found in the "Announcement on the Company's 2025 Profit Distribution Plan" disclosed by the Company on the same day on the CNINFO website (http://www.cninfo.com.cn).
(V) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Proposal on the Company and its Holding Company Applying for Credit Lines from Financial Institutions and the Scope of Guarantees within the Consolidated Financial Statements." The specific content can be found in the "Announcement on the Company and its Holding Company Applying for Credit Lines from Financial Institutions and the Scope of Guarantees within the Consolidated Financial Statements" disclosed by the Company on the same day on the CNINFO website (http://www.cninfo.com.cn).
(VI) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Company's 2025 Internal Audit Work Report."
(VII) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "2025 Internal Control Self-Evaluation Report." The specific content can be found in the "2025 Internal Control Self-Evaluation Report" disclosed by the Company on the same day on the CNINFO website (http://www.cninfo.com.cn).
(VIII) The meeting, by a result of 6 votes in favor, 0 votes against, and 0 abstentions, approved the "Proposal on Re-appointing Lixin Certified Public Accountants (Special General Partnership) as the Company's 2026 Audit Institution." The specific content can be found in the "Announcement on Re-appointing Accounting Firm" disclosed by the Company on the same day on the CNINFO website (http://www.cninfo.com.cn).